[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-329454-105":59,"doc-detail-329454-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","weill-department-of-medicine-annual-report-2020","Weill Department of Medicine - Annual Report 2020","","Weill Department of Medicine Annual Report 2020 summarizes research and clinical performance metrics across FY19 and highlights major developments entering 2020. It reports growth in sponsored research to $80.0 million and grant revenue rising 21%, while noting clinical trial revenue declines and increased patient visits from 2018 to 2019. The chair’s message addresses COVID-19 impacts and ongoing work on racial justice, emphasizing collaboration, excellence, and compassion. The report also features leadership updates, including the appointment of Dr. Laura Alonso as Division Chief.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/weill-department-of-medicine-annual-report-2020/329454/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/weill-department-of-medicine-annual-report-2020/329454.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What key research and revenue trends are reported for FY19?","Question",{"text":112,"@type":113},"Sponsored research increased to $80.0 million from $75.4 million in FY18. Grant revenue rose 21% from $53.1 million to $64.1 million, while clinical trial revenue decreased 28% from $22.3 million to $15.9 million.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did patient visits change from 2018 to 2019?",{"text":117,"@type":113},"Patient visits increased from 275,599 in 2018 to 290,488 in 2019.",{"name":119,"@type":110,"acceptedAnswer":120},"Who was appointed to a leadership role in endocrinology, and what was the focus?",{"text":121,"@type":113},"Dr. Laura Alonso was appointed Chief of the Division of Endocrinology, Diabetes and Metabolism and also appointed Director of the Weill Center for Metabolic Health, with a stated goal of improving patient outcomes in diabetes and related metabolic conditions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},329454,1790433010,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Weill Department of Medicine  \nCare. Discover. Teach.  \nAnnual Report 2020  \nTable of Contents  \nChair’s Message Feature Stories Leadership Honors & Awards Division Profiles Residents & Fellows Contacts In Memoriam  \n1 2  \n14  \n20  \n27  \n62  \n68  \n69  \nIn FY19, the Weill Department of Medicine’s sponsored research portfolio increased to $80.0 million from $75.4 million in FY18 .  \nGrant revenue increased 21% from $53.1 million to $64.1 million, while clinical trial revenue decreased 28% from $22.3 million to $15.9 million.  \nPatient visits increased from  \n275,599 in 2018 to 290,488 in 2019.  \n|  |  |\n| --- | --- |\n| Dear Colleagues and Friends: |  |\n| | This annual report seems different from all others I have been involved with throughout my career. While this report features news highlights from calendar year 2019, it is impossible not to discuss the first several months of 2020. As of this message, weare still in the midst of the COVID-19 pandemic and, at the sametime, working tirelessly on issues of racial justice that pervade our society. From March 6, 2020 onwards, the entire Weill Department of Medicine, along with the other departments at Weill Cornell and our hospital partner, NewYork-Presbyterian, has been focused on providing the most outstanding care and support for the many patients we saw with COVID-19 . I have never been as proud as to see the collaboration, excellence, |\n| and compassion displayed by all members of our department, including our faculty, trainees, and staff. This work continues and will do so for the foreseeable future.\u003Cbr>It is clear that recent events have forever changed medicine and have transformed what Departments of Medicine must do going forward. Prior to the onset of COVID-19, and during the pandemic, our department has upheld its tradition of excellence. Most importantly, the department has excelled in providing high-quality clinical care, advancing state-of-the-art research, and training our next generation of physicians and scientists. We continue to grow and lead nationally in each of these areas.\u003Cbr>Inside this year’s report, you will find examples of some of the wonderful work being done by our outstanding faculty, profiles on each of our divisions, awards received by members of the department, details on educational programs, and information on our administrative structure. In addition, we share details of the arrival of two new Division Chiefs to the department. You will also find metrics of growth covering clinical and research activities during 2019.\u003Cbr>I hope you enjoy the report.\u003Cbr>Sincerely,\u003Cbr>Anthony Hollenberg, M.D.\u003Cbr>Sanford I. Weill Chair of Medicine\u003Cbr>Joan and Sanford I. Weill Department of Medicine Weill Cornell Medical College\u003Cbr>Physician-in-Chief\u003Cbr>NewYork-Presbyterian Hospital/Weill Cornell Medical Center\u003Cbr>\u003Cbr>|  |\n| 1 |  |\n\n\n| Dr. Laura Alonso Appointed to Chief of the Division of Endocrinology, Diabetes and Metabolism: Improving Patient Outcomes\u003Cbr>Recruited from the University of Massachusetts Medical School, where she was the George F. and Sybil H. Fuller Term Chair in Diabetes and the Director of Beta Cell Biological Studies, Dr. Laura Alonso has been appointed to Chief of the Division of Endocrinology, Diabetes and Metabolism in the Weill Department of Medicine. She is also the newly appointed Director of the Weill Center for Metabolic Health. Dr. Alonso, an elected member of the American Society for Clinical Investigation, is a leading physician-scientist in the field of endocrinology and an authority on the basic biology of pancreatic beta cell regeneration.\u003Cbr>From the start of her career, Dr. Alonso has achieved landmark advances in research, beginning with her earliest study on islet biology in which she produced an in vivo mouse model of chronic hyperglycemia induced by direct intravenous glucose infusion. This early model defined Dr. Alonso’s signature state-of-theart approach to research and laid the groundwork for many of her future discover","cbCaidn9zjnyW4pU","https://ap.wps.com/l/cbCaidn9zjnyW4pU","pdf",11673203,72,"English","# Table of Contents\n## Chair’s Message\n## Feature Stories\n## Leadership\n## Honors & Awards\n## Division Profiles\n## Residents & Fellows\n## Contacts\n## In Memoriam","[{\"question\":\"What key research and revenue trends are reported for FY19?\",\"answer\":\"Sponsored research increased to $80.0 million from $75.4 million in FY18. Grant revenue rose 21% from $53.1 million to $64.1 million, while clinical trial revenue decreased 28% from $22.3 million to $15.9 million.\"},{\"question\":\"How did patient visits change from 2018 to 2019?\",\"answer\":\"Patient visits increased from 275,599 in 2018 to 290,488 in 2019.\"},{\"question\":\"Who was appointed to a leadership role in endocrinology, and what was the focus?\",\"answer\":\"Dr. Laura Alonso was appointed Chief of the Division of Endocrinology, Diabetes and Metabolism and also appointed Director of the Weill Center for Metabolic Health, with a stated goal of improving patient outcomes in diabetes and related metabolic conditions.\"}]","Weill Department of Medicine - Annual Report 2020 | PDF",1789984188,181]